Total aflatoxins residues were detected in chicken and turkey tissues "muscles and liver " by using HPLC. Results revealed a significant difference variation among liver and muscles in examined chicken and turkey's samples (p values <0.05). These indicated that liver is the reservoir place of total aflatoxins residues. The means average of Aflatoxin B1, G1, B2, G2 and total aflatoxins residues respectively, in examined chicken liver samples were 17.3+/-3.3 µg/kg, 13.5+/-2.1µg/kg, 7.6+/-4.8 µg/kg ,1.5+/-0.9 µg/kg and 22.8+/-4.1µg/kg. while in examined muscles samples they were 6.5+/-1.03 µg/kg, 4+/-1.4 µg/kg, 1.7+/-0.6 µg/kg, 0.7+/-0.3 µg/kg and 8.9+/-1.5 µg/kg. On the other side the means for Aflatoxin B1, G1, B2, G2 and total aflatoxins residues respectively, in examined turkey liver samples they were 15.6+/-2.7 µg/kg ,13+/-4.2µg/kg, 6.1+/-0.5 µg/kg, 2.2+/-0.6 µg/kg and 24.5+/-4.7 µg/kg, while in turkey muscles samples were 6.3+/-1.5 µg/kg, 4+/-0.2 µg/kg, 2.9+/-1.3 µg/kg, 0.6+/-0.3 µg/kg and 9.3+/-2.5µg/kg.
This study was designed to examine the effect of Effective Microorganisms (EM) in the levels of glucose, cholesterol, triglycerides, high density lipoprotein (HDL), low density lipoprotein (LDL), vary low density lipoprotein (VLDL), alanine amenotransferase (ALT), aspartate amenotransferase (AST) in normal and alloxan-induced diabetic rats and these results were compared with the effect of Glibenclamide as control chemical drug. The results of this study showed that diabetes mellitus induced by alloxan for 30 days caused a significant increase in concentration of serum glucose, cholesterol, triglycerides, low density lipoprotein (LDL), vary low density lipoprotein (VLDL), alanine amenotransferase (ALT), aspartate amenotransferase AST levels. While significantly decreased high density lipoprotein (HDL). The results of this study reveled that administration of (EM) produced asignificant decreased in glucose, cholesterol, triglycerides, low density lipoprotein, vary low density lipoprotein, alanine amenotransferase, aspartate amenotransferase. While significantly increased high density lipoprotein levels of alloxan-induced diabetic rats. Also the results referred that the effect of EM was best the effect of the control chemical drug glibenclamide in its activity.
This study was conducted to investigate the ameliorative effect of lactic acid bacteria Lactobacillus casei and Lactobacillus acidophilus against Potassium bromate (25, 50) mg / kg toxicity by some physiological indicators in 35 of female rats after 21 days. The animals were divided into 7 groups within each group 5 animals weighted 140 – 155 g. The results showed a significant decrease (P<0.05) in value of Red blood cells (RBC), hemoglobin (Hb), White blood cells (WBC), Lymphocyte (LYM) and Platelets (PLT), While increasing the values of Granules (GRN). Also found that the addition of Potassium bromate Potassium bromate led to increase in cholesterol, triglyceride (TG), Low Density Lipoprotein (LDL) and blood glucose, while decreased the values of High Density Lipoprotein (HDL) for rats groups with increasing the concentration of Potassium bromate compared with control group. The addition of two types of lactic acid bacteria L. casei and L. acidophilus with Potassium bromate showed a positive effect to reducing the negative effect of Potassium bromate on blood and lipid profile parameters compared with the control group and Potassium bromate group. It is concluded that the lactic acid bacteria has protective effects and reduces the effects that Potassium bromate.
The current study included 130 people over a period of research from October 2015 to May 2016 who have renal failure and thalassemia. Samples were studied divided in three groups: the first group: included 50 people (62-20 years) with renal failure, and the second group: included 50 people(30-12 years) infected with thalassemia in addition to the 30 people (18-54 years) represented a group of healthy control. The present study aimed to find out the dynamic effect of the hormone erythropoietin and its role in anemia by examining the level of serum hormone erythropoietin among patients with thalassemia as well as anemia in patients with renal failure, in addition to the effect of some of the biochemical parameters associated antioxidants system such as Glutathione (GSH), superoxide dismutase (SOD) and catalase. The study concludes the following results: The results showed a significant decrease (P≤0.01) in the concentration of the erythropoietin hormone in the two groups of patients renal failure while there was a significant increase in patients with a group of thalassemia for males and did not record results significant difference for a group of female thalassemia patients when compared with the control group. The results show that there is a significant decrease in the level of glutathione and SOD and catalase enzyme, and for both males and females in the patients groups when compared with the control group
The current study included 130 people over a period of research from October 2015 to May 2016 who have renal failure, iron deficiency anemia. Samples were studied divided in three groups: the first group: included 50 patients (62-20 years) with renal failure, and the second group: included 50 patients (34-5 years) from anemic iron deficiency, in addition to the 30 healthy persons (18-54 years) represented a group of healthy control. The present study aimed to find out the dynamic effect of the ceroluplasmin and its role in anemia among patients with iron deficiency anemia as well as anemia in patients with renal failure, in addition to the effect of some of the immune status in patients indicators which (IL-4), (IL-6) and (IL-10), The study concludes the following results: The results showed the presence of high-altitude CP in patients groups and for both males and females when compared with the control group. significant rise in the level of and IL- 4, IL-6 and IL- 10 for patients with renal failure, iron deficiency anemia and thalassemia, and for both males and females
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.